Ten-Year Cardiovascular Disease Risk Trajectories by Obstetric History: A Longitudinal Study in the Norwegian HUNT

Abigail Fraser1,2, Amanda R Markovitz3,4,5,6, Eirin B Haug1,2,7

  • 1Population Health Sciences Bristol Medical School University of Bristol Bristol UK.

Insights

Women with pregnancy complications do not require targeted cardiovascular disease (CVD) screening. However, these complications highlight individuals who would benefit from lifestyle changes to reduce future CVD risk.

Area of Science:

  • Cardiovascular disease epidemiology
  • Reproductive health
  • Public health

Background:

  • Women with a history of obstetric complications face elevated cardiovascular disease (CVD) risk.
  • The necessity of specific CVD risk screening for these women remains undetermined.

Purpose of the Study:

  • To investigate whether women with a history of obstetric complications should be specifically targeted for cardiovascular disease (CVD) risk screening.

Main Methods:

  • Utilized linked data from the Norwegian HUNT Study and Medical Birth Registry of Norway.
  • Created a population-based, prospective cohort of parous women.
  • Applied a CVD risk prediction model to estimate 10-year CVD risk based on established risk factors.

Main Results:

  • Predicted 10-year CVD risk scores were consistently higher in women aged 40–60 years with a history of obstetric complications.
  • For example, at age 40, women with preeclampsia had a 0.06 percentage point higher mean risk score than those with normotensive deliveries.
  • Differences in the proportion of women exceeding clinical thresholds for CVD counseling and treatment were modest.

Conclusions:

  • Current findings do not support targeted CVD screening for parous women with pregnancy complications.
  • Pregnancy complications identify women who would benefit from primordial and primary prevention strategies, including behavioral changes to mitigate later-life CVD risk.

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
476
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
498
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
250
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.7K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
389
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
284